Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

19.07
Delayed Data
As of Mar 28
 -0.18 / -0.94%
Today’s Change
15.15
Today|||52-Week Range
39.74
+14.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues190.5M186.5M177.5M196.5M
 
 
 
 
 
Cost of Goods Sold33.6M33.3M30.8M31.4M
 
 
 
 
 
Depreciation And Amortization6.6M6.7M9.2M13.0M
 
 
 
 
 
 
Operating ExpensesGross Income150.3M146.5M137.5M152.1M
 
 
 
 
 
General Expenses107.7M110.8M131.3M137.6M
 
 
 
 
 
Research And Development17.2M19.5M19.4M18.6M
 
 
 
 
 
Total Operating Expenses147.9M150.8M171.3M182.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income42.6M35.7M6.2M14.5M
 
 
 
 
 
Extraordinary Charge0.000.000.00-1.3M
 
 
Interest Expense On Debt0.000.00--2.6M
 
 
Other Expenses200.0K1.2M-2.5M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income43.1M37.3M4.0M12.1M
 
 
 
 
 
Income Taxes-10.5M-13.9M-5.2M-6.2M
 
 
 
 
 
Net Income32.6M23.4M-1.2M5.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS70.9M70.0M68.8M68.2M
 
 
 
 
 
Shares To Calculate EPS Diluted73.5M72.4M68.8M68.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.44$0.32-$0.02$0.09
 
 
 
 
 
EPS Diluted$0.44$0.32-$0.02$0.09